Markes Receives Two Queen’s Awards for Enterprise
Markes International Ltd were officially awarded two Queen’s Awards for Enterprise in September 2019.
Photo Credit: Markes International
Markes International Ltd (Llantrisant, Wales, UK) were officially awarded two Queen’s Awards for Enterprise in September 2019. Markes is one of only 10 Welsh companies to receive an award and one of only six British companies to be recognized in two categories.
“I was absolutely delighted to present the Awards on behalf of Her Majesty The Queen,” said Lord Lieutenant of Mid Glamorgan, Professor Peter Vaughan, QPM, CStJ, DL, as he presented the awards. “It truly is a pleasure to see such an innovative, hard-working, and successful company be given the acknowledgement they deserve.”
Markes received the prestigious awards in the “Innovation” and “International Trade” categories, on the back of their valving technology used in its instruments, as well its continued achievement in growing overseas sales. The pair of awards follow on from success in 2015, when similar business growth led to them receiving a Queen’s Award for International Trade.
The switch-valve, which is the subject of the Innovation Award, was developed and patented by the company in the late 1990s, and is used to regulate flows of gas into and out of a precision-engineered “focusing trap”, with the ultimate aim of collecting, concentrating, and identifying the volatile chemicals present.
The combined operation of the valve and trap allows tiny amounts of chemicals (as low as parts per billion) to be detected routinely, making Markes’ instruments applicable to a wide range of situations. These include forensics and security applications, the monitoring of breath for disease diagnosis, analysis of food and perfume aromas, and testing for toxins in everyday materials and the environment.
The Llantrisant workforce went to the presentation ceremony, which was held at nearby Hensol Castle. “Winning these two awards simply couldn’t have been achieved without the dedication and hard work of all our employees, so we wanted to be sure as many as possible were part of the formal presentation,” said Tim Hawkins, Markes’ Managing Director.
For more information, please visit: www.markes.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
